Global Custom Polyclonal Antibody Development and Production Service 麻豆原创 Research Report 2025

Publication ID:

PB504260342

Publication Date:

May 2, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Custom Polyclonal Antibody Development and Production Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Custom polyclonal antibody development and production service refers to a specialized service offered by biotechnology companies or research institutes for the generation of polyclonal antibodies tailored to meet specific research or diagnostic needs. This service involves the entire process of antibody development, starting from the immunization of host animals with the target antigen to the isolation and purification of the resulting polyclonal antibodies. The service providers work closely with the clients to understand their requirements, including the target antigen, desired application, and specific antibody characteristics. They then design a customized immunization protocol and select the most suitable host animal species for antibody production. The antigen is prepared and injected into the host animals, which triggers an immune response. The serum containing polyclonal antibodies is collected, and the antibodies are purified using various methods such as affinity chromatography or protein A/G purification.
The final purified polyclonal antibodies are tested for their specificity, affinity, and functionality before being supplied to the clients. This service offers researchers a convenient and reliable solution for obtaining high-quality polyclonal antibodies tailored to their specific research needs.
North American market for Custom Polyclonal Antibody Development and Production Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Custom Polyclonal Antibody Development and Production Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Custom Polyclonal Antibody Development and Production Service in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Custom Polyclonal Antibody Development and Production Service include Eurogentec, Leadgene Biomedical, Inc., Biosynth, Fortis Life Sciences, ProteoGenix, Pacific Immunology, Rockland, Abbiotec, Cayman Chemical Company, Creative Biolabs, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Custom Polyclonal Antibody Development and Production Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Custom Polyclonal Antibody Development and Production Service.
The Custom Polyclonal Antibody Development and Production Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Custom Polyclonal Antibody Development and Production Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Custom Polyclonal Antibody Development and Production Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Eurogentec
Leadgene Biomedical, Inc.
Biosynth
Fortis Life Sciences
ProteoGenix
Pacific Immunology
Rockland
Abbiotec
Cayman Chemical Company
Creative Biolabs
ProSci
Sino Biological, Inc.
GenScript ProBio
Thermo Fisher Scientific
Segment by Type
Small-scale
Medium-scale
Large-scale
Segment by Application
Hospital
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Custom Polyclonal Antibody Development and Production Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Custom Polyclonal Antibody Development and Production Service 麻豆原创 Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Small-scale
1.2.3 Medium-scale
1.2.4 Large-scale
1.3 麻豆原创 by Application
1.3.1 Global Custom Polyclonal Antibody Development and Production Service 麻豆原创 Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Research & Academic Laboratories
1.3.4 Pharmaceutical & Biotechnology Companies
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Custom Polyclonal Antibody Development and Production Service 麻豆原创 Perspective (2020-2031)
2.2 Global Custom Polyclonal Antibody Development and Production Service Growth Trends by Region
2.2.1 Global Custom Polyclonal Antibody Development and Production Service 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
2.2.2 Custom Polyclonal Antibody Development and Production Service Historic 麻豆原创 Size by Region (2020-2025)
2.2.3 Custom Polyclonal Antibody Development and Production Service Forecasted 麻豆原创 Size by Region (2026-2031)
2.3 Custom Polyclonal Antibody Development and Production Service 麻豆原创 Dynamics
2.3.1 Custom Polyclonal Antibody Development and Production Service Industry Trends
2.3.2 Custom Polyclonal Antibody Development and Production Service 麻豆原创 Drivers
2.3.3 Custom Polyclonal Antibody Development and Production Service 麻豆原创 Challenges
2.3.4 Custom Polyclonal Antibody Development and Production Service 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Custom Polyclonal Antibody Development and Production Service Players by Revenue
3.1.1 Global Top Custom Polyclonal Antibody Development and Production Service Players by Revenue (2020-2025)
3.1.2 Global Custom Polyclonal Antibody Development and Production Service Revenue 麻豆原创 Share by Players (2020-2025)
3.2 Global Custom Polyclonal Antibody Development and Production Service 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Custom Polyclonal Antibody Development and Production Service Revenue
3.4 Global Custom Polyclonal Antibody Development and Production Service 麻豆原创 Concentration Ratio
3.4.1 Global Custom Polyclonal Antibody Development and Production Service 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Custom Polyclonal Antibody Development and Production Service Revenue in 2024
3.5 Global Key Players of Custom Polyclonal Antibody Development and Production Service Head office and Area Served
3.6 Global Key Players of Custom Polyclonal Antibody Development and Production Service, Product and Application
3.7 Global Key Players of Custom Polyclonal Antibody Development and Production Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Custom Polyclonal Antibody Development and Production Service Breakdown Data by Type
4.1 Global Custom Polyclonal Antibody Development and Production Service Historic 麻豆原创 Size by Type (2020-2025)
4.2 Global Custom Polyclonal Antibody Development and Production Service Forecasted 麻豆原创 Size by Type (2026-2031)
5 Custom Polyclonal Antibody Development and Production Service Breakdown Data by Application
5.1 Global Custom Polyclonal Antibody Development and Production Service Historic 麻豆原创 Size by Application (2020-2025)
5.2 Global Custom Polyclonal Antibody Development and Production Service Forecasted 麻豆原创 Size by Application (2026-2031)
6 North America
6.1 North America Custom Polyclonal Antibody Development and Production Service 麻豆原创 Size (2020-2031)
6.2 North America Custom Polyclonal Antibody Development and Production Service 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Custom Polyclonal Antibody Development and Production Service 麻豆原创 Size by Country (2020-2025)
6.4 North America Custom Polyclonal Antibody Development and Production Service 麻豆原创 Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Custom Polyclonal Antibody Development and Production Service 麻豆原创 Size (2020-2031)
7.2 Europe Custom Polyclonal Antibody Development and Production Service 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Custom Polyclonal Antibody Development and Production Service 麻豆原创 Size by Country (2020-2025)
7.4 Europe Custom Polyclonal Antibody Development and Production Service 麻豆原创 Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Custom Polyclonal Antibody Development and Production Service 麻豆原创 Size (2020-2031)
8.2 Asia-Pacific Custom Polyclonal Antibody Development and Production Service 麻豆原创 Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Custom Polyclonal Antibody Development and Production Service 麻豆原创 Size by Region (2020-2025)
8.4 Asia-Pacific Custom Polyclonal Antibody Development and Production Service 麻豆原创 Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Custom Polyclonal Antibody Development and Production Service 麻豆原创 Size (2020-2031)
9.2 Latin America Custom Polyclonal Antibody Development and Production Service 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Custom Polyclonal Antibody Development and Production Service 麻豆原创 Size by Country (2020-2025)
9.4 Latin America Custom Polyclonal Antibody Development and Production Service 麻豆原创 Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Custom Polyclonal Antibody Development and Production Service 麻豆原创 Size (2020-2031)
10.2 Middle East & Africa Custom Polyclonal Antibody Development and Production Service 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Custom Polyclonal Antibody Development and Production Service 麻豆原创 Size by Country (2020-2025)
10.4 Middle East & Africa Custom Polyclonal Antibody Development and Production Service 麻豆原创 Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurogentec
11.1.1 Eurogentec Company Details
11.1.2 Eurogentec Business Overview
11.1.3 Eurogentec Custom Polyclonal Antibody Development and Production Service Introduction
11.1.4 Eurogentec Revenue in Custom Polyclonal Antibody Development and Production Service Business (2020-2025)
11.1.5 Eurogentec Recent Development
11.2 Leadgene Biomedical, Inc.
11.2.1 Leadgene Biomedical, Inc. Company Details
11.2.2 Leadgene Biomedical, Inc. Business Overview
11.2.3 Leadgene Biomedical, Inc. Custom Polyclonal Antibody Development and Production Service Introduction
11.2.4 Leadgene Biomedical, Inc. Revenue in Custom Polyclonal Antibody Development and Production Service Business (2020-2025)
11.2.5 Leadgene Biomedical, Inc. Recent Development
11.3 Biosynth
11.3.1 Biosynth Company Details
11.3.2 Biosynth Business Overview
11.3.3 Biosynth Custom Polyclonal Antibody Development and Production Service Introduction
11.3.4 Biosynth Revenue in Custom Polyclonal Antibody Development and Production Service Business (2020-2025)
11.3.5 Biosynth Recent Development
11.4 Fortis Life Sciences
11.4.1 Fortis Life Sciences Company Details
11.4.2 Fortis Life Sciences Business Overview
11.4.3 Fortis Life Sciences Custom Polyclonal Antibody Development and Production Service Introduction
11.4.4 Fortis Life Sciences Revenue in Custom Polyclonal Antibody Development and Production Service Business (2020-2025)
11.4.5 Fortis Life Sciences Recent Development
11.5 ProteoGenix
11.5.1 ProteoGenix Company Details
11.5.2 ProteoGenix Business Overview
11.5.3 ProteoGenix Custom Polyclonal Antibody Development and Production Service Introduction
11.5.4 ProteoGenix Revenue in Custom Polyclonal Antibody Development and Production Service Business (2020-2025)
11.5.5 ProteoGenix Recent Development
11.6 Pacific Immunology
11.6.1 Pacific Immunology Company Details
11.6.2 Pacific Immunology Business Overview
11.6.3 Pacific Immunology Custom Polyclonal Antibody Development and Production Service Introduction
11.6.4 Pacific Immunology Revenue in Custom Polyclonal Antibody Development and Production Service Business (2020-2025)
11.6.5 Pacific Immunology Recent Development
11.7 Rockland
11.7.1 Rockland Company Details
11.7.2 Rockland Business Overview
11.7.3 Rockland Custom Polyclonal Antibody Development and Production Service Introduction
11.7.4 Rockland Revenue in Custom Polyclonal Antibody Development and Production Service Business (2020-2025)
11.7.5 Rockland Recent Development
11.8 Abbiotec
11.8.1 Abbiotec Company Details
11.8.2 Abbiotec Business Overview
11.8.3 Abbiotec Custom Polyclonal Antibody Development and Production Service Introduction
11.8.4 Abbiotec Revenue in Custom Polyclonal Antibody Development and Production Service Business (2020-2025)
11.8.5 Abbiotec Recent Development
11.9 Cayman Chemical Company
11.9.1 Cayman Chemical Company Company Details
11.9.2 Cayman Chemical Company Business Overview
11.9.3 Cayman Chemical Company Custom Polyclonal Antibody Development and Production Service Introduction
11.9.4 Cayman Chemical Company Revenue in Custom Polyclonal Antibody Development and Production Service Business (2020-2025)
11.9.5 Cayman Chemical Company Recent Development
11.10 Creative Biolabs
11.10.1 Creative Biolabs Company Details
11.10.2 Creative Biolabs Business Overview
11.10.3 Creative Biolabs Custom Polyclonal Antibody Development and Production Service Introduction
11.10.4 Creative Biolabs Revenue in Custom Polyclonal Antibody Development and Production Service Business (2020-2025)
11.10.5 Creative Biolabs Recent Development
11.11 ProSci
11.11.1 ProSci Company Details
11.11.2 ProSci Business Overview
11.11.3 ProSci Custom Polyclonal Antibody Development and Production Service Introduction
11.11.4 ProSci Revenue in Custom Polyclonal Antibody Development and Production Service Business (2020-2025)
11.11.5 ProSci Recent Development
11.12 Sino Biological, Inc.
11.12.1 Sino Biological, Inc. Company Details
11.12.2 Sino Biological, Inc. Business Overview
11.12.3 Sino Biological, Inc. Custom Polyclonal Antibody Development and Production Service Introduction
11.12.4 Sino Biological, Inc. Revenue in Custom Polyclonal Antibody Development and Production Service Business (2020-2025)
11.12.5 Sino Biological, Inc. Recent Development
11.13 GenScript ProBio
11.13.1 GenScript ProBio Company Details
11.13.2 GenScript ProBio Business Overview
11.13.3 GenScript ProBio Custom Polyclonal Antibody Development and Production Service Introduction
11.13.4 GenScript ProBio Revenue in Custom Polyclonal Antibody Development and Production Service Business (2020-2025)
11.13.5 GenScript ProBio Recent Development
11.14 Thermo Fisher Scientific
11.14.1 Thermo Fisher Scientific Company Details
11.14.2 Thermo Fisher Scientific Business Overview
11.14.3 Thermo Fisher Scientific Custom Polyclonal Antibody Development and Production Service Introduction
11.14.4 Thermo Fisher Scientific Revenue in Custom Polyclonal Antibody Development and Production Service Business (2020-2025)
11.14.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Eurogentec
Leadgene Biomedical, Inc.
Biosynth
Fortis Life Sciences
ProteoGenix
Pacific Immunology
Rockland
Abbiotec
Cayman Chemical Company
Creative Biolabs
ProSci
Sino Biological, Inc.
GenScript ProBio
Thermo Fisher Scientific

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.